JUNE 2019
Dr Rino
Dr Sarita
Volume 56 – April 2019
EBM Pyramid
RCT
Randomization:
Statistical procedure where subjects are randomly allocated
into groups called study/control, to receive or not to receive
a therapy/intervention
Why randomize?
Eliminate bias
Allows comparability
Matches for known and unknown confounding variables
Likely to be more representative of population
Types of randomization
Simple randomization
Block randomization
Stratified randomization
Simple randomization
Flip a coin
Even/odd
Random number table
Pros: Cons
Simple Canresult in unequal no
Easy to implement of participants in each
group
Block randomization
Stratified randomization
Separate block randomisation schemes for
each combination of characteristics
Inclusion criteria:
All inborn neonates with birth weight 750 – 1250g
Exclusion criteria:
Gross congenital GI malformations
Severe birth asphyxia (APGAR <3 at 1min)
Could not establish enteral feeding within first 4 days
Outcomes
Primary outcome: all-cause mortality during hospital
stay
Secondary outcome:
Blood culture proven sepsis
NEC ≥ Stage II*
Feed intolerance#
Survival without major morbidity at discharge
Time to reach full enteral feed (180 ml/kg/d)
Average daily weight gain in NICU after achieving birth
weight (g/kg/day)
*Modified Bell’s staging
#≥1 of: distended/tense/tender abdomen, AG increase >2cm in 2 hr interval, hemorrhagic/bilious aspirate
Outcomes
Secondary outcome:
Survival without major morbidity at discharge
Bronchopulmonary dysplasia*
IVH grade III or IV#
Cystic periventricular leukomalacia@
ROP requiring treatment
Soft abdomen
Study Design
Eligible
Informed neonates
written consent enrolled
Allocation concealment
No blinding
Study design
CR AR
750 – 1000 g
15 ml/kg/d 30 ml/kg/d
+ 15 ml/kg/d + 30 ml/kg/d
1000 – 1250 g
20 ml/kg/d 40 ml/kg/d
+ 20 ml/kg/d + 40 ml/kg/d
Mothers milk (Preterm formula if unavailable)
Parenteral nutrition till 100 – 120 ml/kg/d tolerated
Methods
Baseline maternal, antenatal, intrapartum and
neonatal details recorded
Monitored for NEC and feed intolerance
< 20% - increment
as assigned
Outcome
Abstract
Structured abstract
Trial design
Methods
Results
Conclusions
Introduction
Scientific background
Explained rationale
Stated hypothesis
Location of study
Interventions Well detailed
Outcomes Well defined primary and secondary outcomes
No changes made once trial started
Implementation
Blinding Not done
Statistical Mentioned
analysis
Results
Participant flow Depicted